Michael Pichichero: Difference between revisions

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 00:51, 13 October 2013 editAfasmit (talk \| contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers69,535 editsm defaultsort← Previous edit		Revision as of 01:23, 4 November 2013 edit undoSandyGeorgia (talk \| contribs)Autopatrolled, Extended confirmed users, Page movers, File movers, Mass message senders, New page reviewers, Pending changes reviewers, Rollbackers, Template editors279,026 edits →Scientific Work: represent what source saysNext edit →
(5 intermediate revisions by 2 users not shown)
Line 44:		Line 44:

	==Biography==		==Biography==
	Pichichero received his undergraduate degree from ], and his medical degree from the ].		Pichichero received his undergraduate degree from ], and his medical degree from the ].{{cn}}

	==Scientific Work==		==Scientific Work==
		⚫	Pichero's studies say that ethylmercury, the metabolite of thimerosal, is rapidly metabolized and excreted after administration of TCVs, as well as that administration thereof does not raise blood mercury levels above the ]'s lower limit. In addition, his research has concluded that ethylmercury is metabolized about six times as fast as ] (the kind of mercury found in fish).<ref>{{cite web \| url=http://www.medscape.com/viewarticle/445538 \| title=Mercury in Vaccines: A Newsmaker Interview With Michael E. Pichichero, MD \| publisher=] \| date=3 December 2002 \| accessdate=31 August 2013 \| author=Barclay, Laurie}}</ref> His research says that after children receive a vaccine with thimerosal in it, their blood mercury levels return to normal within only a month.<ref>{{cite web \| url=http://usatoday30.usatoday.com/news/health/2008-01-31-vaccines-mercury_N.htm \| title=Study: Mercury fades quickly from blood \| work=] \| date=31 January 2008 \| accessdate=31 August 2013 \| author=Johnson, Carla K.}}</ref>
	He is the author of a number of scientific studies regarding the safety of ] as a preservative in vaccines, which have been published in, among other journals, '']''<ref>{{cite doi\|10.1016/S0140-6736(02)11682-5}}</ref> and '']''.<ref>{{cite doi\|10.1542/peds.2006-3363}}</ref>

⚫	~~These~~ studies ~~have, in general, concluded~~ that ethylmercury, the metabolite of thimerosal, is rapidly metabolized and excreted after administration of TCVs, as well as that administration thereof does not raise blood mercury levels above the ]'s lower limit. In addition, ~~Pichichero's~~ research has concluded that ethylmercury is metabolized about six times as fast as ] (the kind of mercury found in fish).<ref>{{cite web \| url=http://www.medscape.com/viewarticle/445538 \| title=Mercury in Vaccines: A Newsmaker Interview With Michael E. Pichichero, MD \| publisher=] \| date=3 December 2002 \| accessdate=31 August 2013 \| author=Barclay, Laurie}}</ref> ~~Specifically, his~~ research ~~has concluded~~ that after children receive a vaccine with thimerosal in it, their blood mercury levels return to normal within only a month.<ref>{{cite web \| url=http://usatoday30.usatoday.com/news/health/2008-01-31-vaccines-mercury_N.htm \| title=Study: Mercury fades quickly from blood \| work=] \| date=31 January 2008 \| accessdate=31 August 2013 \| author=Johnson, Carla K.}}</ref> Pichichero has also written a textbook about ].<ref>{{cite book \| url=http://books.google.com/books?id=IoXXTgfDELEC \| title=Clinical Management of Streptococcal Pharyngitis \| publisher=Professional Communications \| author=Pichichero, Michael \| year=2007}}</ref> A board-certified immunologist, he, along with other scientists at the University of Rochester, helped invent the ]. His more recent research, however, has focused on ], as well as a syndrome his lab discovered and termed, "PNIP (Prolonged Neonatal Immune Profile)".<ref>{{cite web \| url=http://www.rochestergeneral.org/research-and-clinical-trials/rochester-general-hospital-research-institute/our-researchers/ \| title=Our Researchers \| publisher=] \| accessdate=31 August 2013}}</ref> His ] is 56.<ref>{{cite web \| url=http://scholar.google.com/scholar?q=author%3A%22Pichichero+ME%22&btnG=&hl=en&as_sdt=0%2C1 \| title=Results for Pichichero ME \| work=] \| accessdate=3 September 2013}}</ref>
			Pichichero has written a textbook about ].<ref>{{cite book \| url=http://books.google.com/books?id=IoXXTgfDELEC \| title=Clinical Management of Streptococcal Pharyngitis \| publisher=Professional Communications \| author=Pichichero, Michael \| year=2007}}</ref> A board-certified immunologist, he was on the team of scientists at the University of Rochester who invented the ].<ref name=Rochester/> His more recent research, however, has focused on ], as well as a syndrome his lab discovered and termed, "PNIP (Prolonged Neonatal Immune Profile)".<ref name=Rochester>{{cite web \| url=http://www.rochestergeneral.org/research-and-clinical-trials/rochester-general-hospital-research-institute/our-researchers/ \| title=Our Researchers \| publisher=] \| accessdate=31 August 2013}}</ref>

	==Selected publications==		==Selected publications==
	*{{cite pmid\|9470015}}		*{{cite pmid\|9470015}}

Revision as of 01:23, 4 November 2013

Michael E. Pichichero
Alma mater	University of Rochester School of Medicine
Known for	Thimerosal controversy
Awards	Breese Award for Outstanding Contribution to Clinical Research, Teaching and Practice, 2005
Scientific career
Fields	Pediatrics, toxicology
Institutions	University of Rochester Medical Center

Michael E. Pichichero, MD is a clinical professor in the Department of Pediatrics at the University of Rochester Medical Center. He is the author of a number of scientific studies regarding the safety of thimerosal as a preservative in vaccines.

Biography

Pichichero received his undergraduate degree from Rutgers University, and his medical degree from the University of Rochester.

Scientific Work

Pichero's studies say that ethylmercury, the metabolite of thimerosal, is rapidly metabolized and excreted after administration of TCVs, as well as that administration thereof does not raise blood mercury levels above the EPA's lower limit. In addition, his research has concluded that ethylmercury is metabolized about six times as fast as methylmercury (the kind of mercury found in fish). His research says that after children receive a vaccine with thimerosal in it, their blood mercury levels return to normal within only a month.

Pichichero has written a textbook about streptococcal pharyngitis. A board-certified immunologist, he was on the team of scientists at the University of Rochester who invented the Hib vaccine. His more recent research, however, has focused on otitis media, as well as a syndrome his lab discovered and termed, "PNIP (Prolonged Neonatal Immune Profile)".

Selected publications

Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 9470015, please use {{cite journal}} with |pmid=9470015 instead.
Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15805383, please use {{cite journal}} with |pmid=15805383 instead.
Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 20335823, please use {{cite journal}} with |pmid=20335823 instead.

References

"Meet our Doctors". Legacy Pediatrics. Retrieved 31 August 2013.
"Michael E. Pichichero". University of Rochester Medical Center. Retrieved 31 August 2013.
Barclay, Laurie (3 December 2002). "Mercury in Vaccines: A Newsmaker Interview With Michael E. Pichichero, MD". Medscape. Retrieved 31 August 2013.
Johnson, Carla K. (31 January 2008). "Study: Mercury fades quickly from blood". USA Today. Retrieved 31 August 2013.
Pichichero, Michael (2007). Clinical Management of Streptococcal Pharyngitis. Professional Communications.
^ "Our Researchers". Rochester General Health System. Retrieved 31 August 2013.

External links

This biographical article about a scientist is a stub. You can help Misplaced Pages by expanding it.

Categories: